2Patel SS, Balfoud JA, Bryson HM. Fosfomycin trornethamine Areviewof its antibacterial activity, Pharmacokinetic ProPerties and therapeutic efficacy as a single-dose oral treatment-for acute uncomplicated lower urinary tract infections[J]. Drugs, 1997, 53(4) :637.
3Forestier F, salvanet-Bouccara-A,Leveques-D, et al. Ocular Penetration Kinetics of fosfomycin administered as a one-hour infusion[J]. Eur J Ophthalmol, 1996, 6(2):137.
4Scaglione F,cicchetti F, Demartini G, et al. Fosfomycin distribution in the lower urinary tract after administration of fosfomycin trometamol salt[J]. Int J elin Pharmacol Res, 1994,14(3):107.
5Legat FJ, Maier A, Dittrich P,et al. Penetration of fosfomycin into inflammatory Lesions in Patients with Cellulitis or diabetic foot syndrome[J]. Antimicrob Agents Chemother, 2003,47(1):371.
6Kitamura K, Hirai H, Hosoya N,et al. Clinical efficacy of fosfomycin in combination with Sulbactam/cefoperazone in the treatment of Severe infections Complicated to blood dyscrasia. Working Group of Kanto Combination Therapy for FOM + SBV/cpz[J]. Kansens hogaku Z,asshi, 1998, 72(7):761.
7Morikawa K,OseKO F,Morikawa S. Immunomodulatory effect of fosfomycin on human B-lymphocyte function[J]. Antimicrob Agent s Chemother, 1993,37 (2) : 270.
8Corti N,Sennha FH,Stauffer UG,et al. Fosfomycin for the initial treatment of acute haematogenous Osteomyelitis[J]. Arch Dis Child, 2003,88(6) : 512.
9Stein GE. Single-dose treatment of acute cystitis with fosfomycin tromethamine[J]. Ann-Pharmacother, 1998,32 (2) : 215.
10Kamijyo A,MatsuzaKi Z, Kikushima K, et al. Fosfomycin nebulizer therapy to chronic sinustitis[J]. Auris Nasus Larynx, 2001,28(3) : 227.
